Insulin detemir Subcutaneous and Ramucirumab Intravenous
Determining the interaction of Insulin detemir Subcutaneous and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir Subcutaneous-Ranexa
- Insulin detemir Subcutaneous-Ranibizumab
- Insulin detemir Subcutaneous-Ranibizumab Intraocular
- Insulin detemir Subcutaneous-Ranibizumab ophthalmic
- Insulin detemir Subcutaneous-Ranitidine
- Insulin detemir Subcutaneous-Ranitidine Capsule
- Ramucirumab Intravenous-Insulin glargine
- Ramucirumab Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Ramucirumab Intravenous-Insulin Glargine (U-100) Vials
- Ramucirumab Intravenous-Insulin Glargine (U-300) Pens
- Ramucirumab Intravenous-Insulin glargine and lixisenatide
- Ramucirumab Intravenous-Insulin glargine and lixisenatide Subcutaneous